ACCC, CMA, & NCCN News

The following information has been received by ANCO.


****ACCC NEWS****
The Association of Community Cancer Center's (ACCC) This Week At ACCC was published and is available at http://www.accc-cancer.org/mediaroom/newsletters/2009/media_ACCCNEWSLETTER_2-23-2009.html. ANCO is an Institutional Member of ACCC. This edition features:

An Economic Stimulus Package Just for You at ACCC's Annual National Meeting

Sneak Peek: ACCC Meeting to Showcase More Than 60 Exhibitors

ACCC Testifies at APC Panel Meeting, Panel Makes Recommendations for 2010

CMS's RAC Program Reinstated

Economic Stimulus Legislation Includes Funds for Healthcare IT, Prevention

CMS Memo Proposes No Coverage of Screening CT Colonography

ACCC Seeks MORE Cancer Program Administrators to Take Our Survey

Q&A on ACCC's Listserv: Clinical Research Update, Percent Accruals

ACCC's CE Blackboard: A Full Range of Courses

Check Out ACCC's Facebook Page

State Medical Oncology Societies Host Membership Meetings


****CMA NEWS****
The California Medical Association's (CMA) Alert was published today and is available online at http://www.calphys.org/html/news.asp. This edition features:

Schwarzenegger Signs Budget Deal; Medi-Cal Largely Unscathed

Stimulus Package Provides $87 Billion for Medicaid Programs; $19 Billion for HIT

Joint Commission Requires Ongoing Collection of Physician Performance Data

It’s Time to Prebook Vaccine for 2009-2010 Flu Season

Leadership Academy Registration Is Now Open

Don't Miss These Upcoming CMA Webinars

Last Chance to Take CMA's Physician Survey

Member Benefit of the Week: 6% off athenaCollector


****NCCN NEWS****
NCCN Chemotherapy Order Templates™
based on the NCCN Clinical Practice Guidelines in Oncology™
and the NCCN Drugs & Biologics Compendium™

Newly released NCCN Chemotherapy Order Templates™:

• Non-Small Cell Lung Cancer
• Uterine Neoplasms

NCCN is developing a library of chemotherapy order templates to improve the safe use of drugs and biologics in cancer care. The information contained in the NCCN Templates is based on the NCCN Clinical Practice Guidelines in Oncology™ and the NCCN Drugs & Biologics Compendium™. The NCCN Templates include chemotherapy, hormone therapy, immunotherapy, supportive care agents, monitoring parameters, and safety instructions. Special instructions for self-administered chemotherapeutic agents are provided.

The following NCCN Templates are now available: Bladder Cancer, Breast Cancer, Cervical Cancer, Chronic Myelogenous Leukemia, Colon Cancer, Hepatobiliary Cancers, Kidney Cancer, Non-Small Cell Lung Cancer, Ovarian Cancer, Prostate Cancer, Small Cell Lung Cancer,Testicular Cancer, and Uterine Neoplasms.

Coming Soon: Acute Myeloid Leukemia, Bone Cancer, Central Nervous System Cancers, Chronic Lymphocytic Leukemia, Esophageal Cancer, Gastric Cancer, Head and Neck Cancers, Hodgkin Disease/Lymphoma, Melanoma, Multiple Myeloma, Myelodysplastic Syndromes, Neuroendocrine Tumors, Non-Hodgkin's Lymphoma, Non-Melanoma Skin Cancers, Occult Primary, Pancreatic Adenocarcinoma, Rectal Cancer, Soft Tissue Sarcoma, and Thyroid Carcinoma.

Disclaimer: These templates are a peer-reviewed statement of the consensus of the authors derived from the NCCN Clinical Practice Guidelines in Oncology™ regarding their views of currently accepted approaches to treatment. These templates do not constitute orders. Any clinician seeking to treat a patient using the templates is expected to use independent medical judgment in the context of individual clinical circumstances of a specific patients care or treatment. NCCN disclaims all warranties, express or implied including, without limitation, the implied warranties of merchantability and fitness for a particular purpose. NCCN does not warrant the accuracy, currency or completeness of the templates or make any representation regarding the use or the results of the use of the templates in treatment. In no event shall NCCN or its members be liable for any damages including without limitation incidental, indirect, special, punitive or consequential damages arising out of or in connection with the use of the templates including, without limitation, loss of life, loss of data, loss of income or profit, losses sustained as a result of any injury to any person, or loss or damage to property or claims of third parties.

Access the latest updates at www.nccn.org.